RBC Capital Reiterates Outperform on CenterPoint Energy, Maintains $33 Price Target
RBC Capital analyst Shelby Tucker reiterates CenterPoint Energy (NYSE:CNP) with a Outperform and maintains $33 price target.
RBC Capital Reiterates Outperform on G Mining Ven, Maintains C$2 Price Target
RBC Capital analyst Michael Siperco reiterates G Mining Ven (TSXV:GMIN) with a Outperform and maintains C$2 price target.
Mizuho Reiterates Buy on Oracle, Maintains $116 Price Target
Mizuho analyst Siti Panigrahi reiterates Oracle (NYSE:ORCL) with a Buy and maintains $116 price target.
Credit Suisse Reiterates Outperform on Dell Technologies, Maintains $50 Price Target
Credit Suisse analyst Anthony Crowdell reiterates Dell Technologies (NYSE:DELL) with a Outperform and maintains $50 price target.
Oppenheimer Reiterates Outperform on BioLife Solns, Maintains $28 Price Target
Oppenheimer analyst Suraj Kalia reiterates BioLife Solns (NASDAQ:BLFS) with a Outperform and maintains $28 price target.
Needham Reiterates Buy on Extreme Networks, Maintains $23.5 Price Target
Needham analyst Alex Henderson reiterates Extreme Networks (NASDAQ:EXTR) with a Buy and maintains $23.5 price target.
HC Wainwright & Co. Reiterates Buy on Jazz Pharmaceuticals, Maintains $204 Price Target
HC Wainwright & Co. analyst Oren Livnat reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $204 price target.
HC Wainwright & Co. Reiterates Buy on Keros Therapeutics, Maintains $100 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Keros Therapeutics (NASDAQ:KROS) with a Buy and maintains $100 price target.
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $16 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $16 price target.
Needham Reiterates Buy on Shutterstock, Maintains $90 Price Target
Needham analyst Bernie McTernan reiterates Shutterstock (NYSE:SSTK) with a Buy and maintains $90 price target.